SCHEMBL5044858

SCHEMBL5044858

CCCCCCCCCCCc1noc(-c2cccc(C([NH])Cc3ccccc3OC)c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 3/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
PKM P14618 1/20 0.40
LMNA P02545 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
SPHK2 Q9NRA0 2/20 0.37
SPHK1 Q9NYA1 2/20 0.37
USP2 O75604 1/20 0.37
NPY2R P49146 1/20 0.37
APLNR P35414 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047684 0.90 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL5044867 0.82 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL5039878 0.81 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL6802901 0.80 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL5044424 0.80 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL1853006 0.79 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL1851803 0.78 CHRM2 (0.40) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL1854447 0.77 ACHE (0.48) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL5039990 0.76 SPHK1 (0.41) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL7064619 0.76 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732534-B1 USE OF METHYLENE AMIDE DERIVATIVES IN CARDIOVASCULAR DISORDERS SERONO LAB (CH) 2008-07-23 EP claimed